Speaker Faculty | Novel Format Conjugates Summit

Andrea Galbiati

Research Scientist

Philochem

Cari Meisel

Director of Research & Development

NanoTomer

Neil Bander

Professor

Weill Cornell - Cornell University

Robert Huang

Founder & Chief Executive Officer

Coherent Biopharma

Christian Marsolais

Chief Medical Officer & Vice President of Medical Affairs

Theratechnologies

Christina McGuire

Senior Scientist

Guardian Therapeutics

David Owen

Vice President Research & Development

Starpharma

Edward Barnes

Technical Director

Aptamer Group

Fu-An Kang

Vice President Research

miRecule

Gavin Bennet

Head of Pre-Clinical Development

Bicycle Therapeutics

Gordon Rigg

Principal Consultant

Apex Biologics Consulting

Hans Georg Lerchen

Chief Scientific Officer

Vincerx Pharma

Jarrod Longcor

Chief Business Officer & SVP of Operations

Cellectar Biosciences

John Flygare

Senior Principal Scientist

Merck

Mahendra Deonorain

Chief Executive Officer, Chief Science & Operating Officer

Antikor Biopharma

Nicolas Camper

Senior Director, Chemistry

Abzena

Michael Alonso

Vice President of Immunology & Pharmacology

Bolt Biotherapeutics

Mike Wheatcroft

Chief Scientist

Telix Pharmaceuticals

Mingchao Kang

Project Leader, EuCode

Ambrx

Nick Yoder

Direction, Bioconjugation

Magenta Therapeutics

Ramana Doppalapudi

Vice President of Chemistry

Avidity Biosciences

Ruben Postel

Founder & Chief Scientific Officer

Sapreme Technologies

Shelley Ackerman

Associate Director & Project Team Lead

Bolt Biotherapeutics

Thomas Tulip, PhD

Chief Technology Officer

Radiopharm Theranostics

Gregory Adams

Chief Scientific Officer

Elucida Oncology Inc.

Timothy Weeden

Senior Director & Head of Platform Development

Dyne Therapeutics

Yi-Shen Zhu